L1CAM and renal cell adenocarcinoma: The subgroup analysis of different cancer types showed a similar significant association between L1CAM expression and OS in colorectal cancer, ovarian cancer, neuroendocrine tumours, gastric cancer, cholangiocarcinoma, renal cell cancer, non-small cell lung cancer, hepatocellular cancer, endometrial cancer and vulvar cancer.